Basic Information
Bexson Biomedical is developing a unique ketamine formulation for the treatment of chronic and acute pain disorders. The opioid crisis is a public health emergency in the United States. There is an urgent need for safe and effective treatments. For millions of pain patients, this is a true alternative to opioid pain treatment.
Bexson Biomedical, Inc.
California,United States of America
15~50 people
January 01, 2017
info@neurocycletherapeutics.com

